Cybin (CYBN.NE) selects SAD and GAD as targets for their CYB004 psychedelic molecule Post date June 16, 2021 Posted by Piers Eaton Posted in CYB004, cybin, CYBN.NE, GAD, Generalized Anxiety Disorder, Health Science, mental health, Mushroom Moves, Mushrooms, psilocybin, Psychedelics, SAD, Series, shrooms, Social Anxiety Disorder Comments 0